Adjuvant Global Health Technology Fund, L.p. - Net Worth and Insider Trading
Adjuvant Global Health Technology Fund, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adjuvant Global Health Technology Fund, L.p. owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .
Insider Ownership Summary of Adjuvant Global Health Technology Fund, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2022-03-24 | 10 percent owner |
Adjuvant Global Health Technology Fund, L.p. Trading Performance
Adjuvant Global Health Technology Fund, L.p. Ownership Network
Adjuvant Global Health Technology Fund, L.p. Owned Company Details
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Adjuvant Global Health Technology Fund, L.p. is the 10 percent owner of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include Chief Development Officer Sanjay Chanda , Chief Financial Officer Lucy Day , and See Remarks Joshua M Eizen .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Adjuvant Global Health Technology Fund, L.p. made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Kabeer Aziz , a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , and a net purchase of 329,906 shares made by Robin Shane Readnour .
In summary, during the past 3 months, insiders sold 17,606 shares of AN2 Therapeutics Inc (ANTX) in total and bought 412,000 shares, with a net purchase of 394,394 shares. During the past 18 months, 4,108,331 shares of AN2 Therapeutics Inc (ANTX) were sold and 3,689,778 shares were bought by its insiders, resulting in a net sale of 418,553 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
Adjuvant Global Health Technology Fund, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Adjuvant Global Health Technology Fund, L.p.. You might contact Adjuvant Global Health Technology Fund, L.p. via mailing address: C/o Adjuvant Capital, L.p., 501 Fifth Avenue, Suite 1404, New York Ny 10017.
Discussions on Adjuvant Global Health Technology Fund, L.p.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
